Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Chronic kidney disease (CKD) is a global health issue characterized by declining renal function.
• CKD leads to the accumulation of uremic toxins, negatively impacting cellular function and the cardiovascular system.
• Cardiovascular diseases are the leading cause of mortality in patients with all stages of renal failure.

Purpose of the Study:

• To explore the link between chronic kidney disease, uremic toxins, oxidative stress, and cardiovascular complications.
• To investigate the role of the kidney as a source of antioxidant enzymes and the consequences of its impairment.
• To evaluate the potential benefits of antioxidant therapies in managing cardiovascular risks associated with CKD.

Main Methods:

• Review of existing literature on CKD pathophysiology and cardiovascular comorbidities.
• Analysis of the mechanisms by which uremic toxins contribute to oxidative stress.
• Examination of the impact of hemodialysis on oxidative stress levels.

Main Results:

• Impaired kidney function in CKD is associated with reduced antioxidant enzyme levels and increased pro-oxidants.
• Uremic toxins are key contributors to oxidative stress in CKD.
• Hemodialysis can exacerbate oxidative stress, which is linked to kidney and cardiac damage, including cardiac hypertrophy.

Conclusions:

• Elevated oxidative stress in CKD exacerbates kidney dysfunction and cardiac damage.
• Antioxidant therapies show promise in mitigating oxidative stress, reducing uremic cardiovascular toxicity, and potentially improving patient survival.